Veligrotug-vvze (Lumvoa)
Dilution requiredFull monograph review pending
U.S. label preparation
Lumvoa · Dilution required
- Preparation
- Use a 250 mL bag of 0.9% sodium chloride. Remove the label-specified volume and replace it with the weight-based drug volume. Gently invert.
- Administration and handling
- Give the first infusion over 45 minutes. If tolerated, later infusions may run over at least 30 minutes.
- Manufacturer's storage limits
- For the diluted saline bag, the label permits 4 hours at 20-25 C or up to 72 hours at 2-8 C, protected from light. Do not freeze. Allow refrigerated solution to reach room temperature before infusion. A compounding beyond-use date requires a separate assessment.
Product and source details
Viridian Therapeutics, Inc. · BLA761530
Product NDC: 85166-001
SPL effective 2026-06-29 | SPL version 7. Checked 2026-11-13.
Source for this summary: U.S. prescribing information. Use the full label for dose selection, contraindications, preparation tables and monitoring.
Product identifiers and clinical review status
U.S. label preparation available. Full monograph review pending.
Exact formulation, concentration, container, manufacturer, regulatory identifiers, and a reproducible label snapshot have not all been reconciled.
What remains to be completed
- Obtain independent corroboration of the label preparation where available.
- Complete indication- and age-specific dosing, incompatibility, monitoring and stability review.
- Assess any proposed compounding BUD for the exact formulation, concentration, container and conditions.